Henry A Fernandez - Net Worth and Insider Trading
Henry A Fernandez Net Worth
The estimated net worth of Henry A Fernandez is at least $1.2 Billion dollars as of 2025-01-13. Henry A Fernandez is the Chairman and CEO of MSCI Inc and owns about 2,106,446 shares of MSCI Inc (MSCI) stock worth over $1.2 Billion. Henry A Fernandez is also the Director of Royalty Pharma PLC and owns about 76,136 shares of Royalty Pharma PLC (RPRX) stock worth over $2 Million. Details can be seen in Henry A Fernandez's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry A Fernandez has not made any transactions after 2024-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry A Fernandez
Henry A Fernandez Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry A Fernandez owns 2 companies in total, including Royalty Pharma PLC (RPRX) , and MSCI Inc (MSCI) .
Click here to see the complete history of Henry A Fernandez’s form 4 insider trades.
Insider Ownership Summary of Henry A Fernandez
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RPRX | Royalty Pharma PLC | 2022-06-24 | director |
MSCI | MSCI Inc | 2024-12-05 | director & Chairman & CEO and President |
Henry A Fernandez Latest Holdings Summary
Henry A Fernandez currently owns a total of 2 stocks. Among these stocks, Henry A Fernandez owns 2,106,446 shares of MSCI Inc (MSCI) as of December 5, 2024, with a value of $1.2 Billion and a weighting of 99.82%. Henry A Fernandez also owns 76,136 shares of Royalty Pharma PLC (RPRX) as of February 24, 2022, with a value of $2 Million and a weighting of 0.18%.
Latest Holdings of Henry A Fernandez
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MSCI | MSCI Inc | 2024-12-05 | 2,106,446 | 575.73 | 1,212,744,156 |
RPRX | Royalty Pharma PLC | 2022-02-24 | 76,136 | 29.49 | 2,245,251 |
Holding Weightings of Henry A Fernandez
Henry A Fernandez Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry A Fernandez has made a total of 2 transactions in MSCI Inc (MSCI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in MSCI Inc is the acquisition of 2,900 shares on December 5, 2024, which cost Henry A Fernandez around $2 Million.
According to the SEC Form 4 filings, Henry A Fernandez has made a total of 2 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Royalty Pharma PLC is the acquisition of 32,500 shares on February 24, 2022, which cost Henry A Fernandez around $1 Million.
Insider Trading History of Henry A Fernandez
- 1
Henry A Fernandez Trading Performance
GuruFocus tracks the stock performance after each of Henry A Fernandez's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry A Fernandez is -10.95%. GuruFocus also compares Henry A Fernandez's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry A Fernandez within 3 months outperforms 4 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry A Fernandez's insider trading performs compared to the benchmark.
Performance of Henry A Fernandez
Henry A Fernandez Ownership Network
Ownership Network List of Henry A Fernandez
Ownership Network Relation of Henry A Fernandez
Henry A Fernandez Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Henry A Fernandez is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Henry A Fernandez made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 934,197 shares made by Avara Management Ltd , a net sale of 470,000 shares made by Rory B Riggs , and a net sale of 75,000 shares made by Terrance P. Coyne .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,479,197 shares of Royalty Pharma PLC (RPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,479,197 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Henry A Fernandez Mailing Address
Above is the net worth, insider trading, and ownership report for Henry A Fernandez. You might contact Henry A Fernandez via mailing address: Msci Inc., 88 Pine Street, New York Ny 10005.